Among the 50 patients (median age, 66 years; 64% male), high Vimentin expression was significantly associated with vascular invasion (adjusted OR, 2.90; 95% CI, 1.05–7.62; P = 0.031), lymph node metastasis (OR, 2.62; 95% CI, 1.03–8.12; P = 0.042), distant metastasis (OR, 3.10; 95% CI, 1.01–12.54; P = 0.048), and larger tumor size (P = 0.004). Here, VIM is linked to metastatic malignant neoplasm in the lymph nodes.